Indazole: A medicinally important heterocyclic moiety

Medicinal Chemistry Research

Volumn 21, Issue 7, 2012, Pages 1509-1523

  Thangadurai, Ananda ^a   Minu, Maninder ^b   Wakode, Sharad ^c   Agrawal, Shyam ^c   Narasimhan, Balasubramanian ^d  

^a SWAMY VIVEKANANDHA COLLEGE OF PHARMACY   (India)

^b DAYALBAGH EDUCATIONAL INSTITUTE   (India)

^c DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^d MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

Anti inflammatory; Anticancer; Antimicrobial; Indazole

Indexed keywords

(1 METHYL 3,5,6,7 TETRAHYDRO INDAZOL 4 YLIDENEAMINOOXY)ACETIC ACID; (5 TERT BUTYL 2,3 DIHYDRO 1H INDEN 1 YL) 3 (1H INDAZOL 4 YL)UREA; 1 (3,4 DICHLOROBENZYL) 3 (1H INDAZOL 4 YL)UREA HYDROCHLORIDE; 1 BENZYL 3 (2,3 DIHYDROXYPROPOXY)INDAZOLE; 1 METHYL 1H INDAZOLE 4 ACETIC ACID; 1 PHENYL 4,5,6,7 TETRAHYDRO 1H INDAZOLE 5 CARBOXYLIC ACID; 2 (1 METHYL 1H INDAZOL 4 YL)PROPANOIC ACID; 2 (7 BENZYLIDENE 3 PHENYL 3,3A,4,5,6,7 HEXAHYDROINDAZOL 2 YL) 5 (4 CHLORO BENZYL)THIAZOL 4 ONE; 2 [(1 PHENYL 1H INDAZOL 4 YL)OXY]ETHANAMINES; 2 [5 (1H INDAZOL 5 YL)PYRIDIN 3 YLOXY] 1 (1H INDOL 2 YLMETHYL)ETHYLAMINE; 2 ARYLIDENE 6 FURFURYLIDENE CYCLOHEXANONES; 2 BENZYL 3 PHENYLAMINO 4,5 DIHYDRO 2H BENZ[G]INDAZOLES; 2,3 DIPHENYL 7 (5 NITROFURFURYLIDENE) 3,3A,4,5,6,7 HEXAHYDROINDAZOLE; 3 (5 BROMO INDAZOL 1 YL) 2 (2,4 DIFLUORO PHENYL) 1 [1,2,4]TRIAZOL 1 YL BUTAN 2 OL; 3 (5 NITROFURYL) 7 (5 NITROFURFURYLIDEN) 3,3A,4,5,6,7 HEXAHYDRO 2H INDAZOLE; 3 (5' HYDROXYMETHYL 2' FURYL) 1 BENZYL INDAZOLE; 3 [(1 PHENYL 1H INDAZOL 4 YL)OXY]PROPANAMINES; 3 PHENYL 2 [4 (TRIFLUOROMETHYL)PHENYL] 4,5,6,7 TETRAHYDRO 2H INDAZOLE; 3,9 DIOXO 3H,9H PYRAZOLO[1,2 A]INDAZOLE; 4,8 DIPHENYL 10 TRIFLUOROMETHYL 1,2,3,4 TETRAHYDRO PYRIMIDO[1,2 B]INDAZOLE 7 CARBONITRILE; 5 BENZYL 1 PHENYL 1H INDAZOL 4 OL; 5 METHOXY 1 [(QUINOLINE 2 YLMETHOXY)BENZYL] 1H INDAZOL 3 OL; 6 (4 BROMOPHENYL)AMINO 7 (4 CHLOROPHENYL)INDAZOLO[2',3':1,5] 1,2,4 TRIAZOLO[4,3 A] 1,3,5 BENZOTRIAZEPINE; [(1 PHENYL 1H INDAZOL 4 YL)OXY]ACETIC ACID; BINDARIT; ETHYL 5 METHYL N1 4 CHLOROBENZOYL 1H INDAZOLE 3 CARBOXYLATE; HEXAHYDROINDAZOLES; INDAZOLE DERIVATIVE; PYRIDAZINO[1,2 A]INDAZOLE 6,9,11 TRI ONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE PANCREATITIS; ANALGESIA; ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIPYRETIC ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CARTILAGE DEGENERATION; COLON CANCER; CYTOKINE PRODUCTION; DIABETIC NEUROPATHY; DRUG SYNTHESIS; ENTEROCOCCUS; ENZYME INHIBITION; ESCHERICHIA COLI; HUMAN; HYPERALGESIA; HYPERTENSION; KIDNEY CANCER; LEUKEMIA; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; OBESITY; OSTEOARTHRITIS; OVARY CANCER; PROSTATE CANCER; PROTEUS; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS INFECTION;

EID: 84861910037     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9631-3     Document Type: Review

References (63)

1. Abouzid KA, El-Abahr HS (2003) Synthesis and antiinflammatory activity of novel indazolones. Arch Pharm Res 26:1-8
2. Alisi MA, Cazzolla N, Furlotti G, Guglielmotti A, Polenzani L (2010) US Pat. US 7,662,836 B2
3. Baldwin JJ, Claremon DA, Dillard LW, Ishchenko AV, Yuan J, Xu Z, McGeehan G, Zeng W (2010) Us Pat. US 2010/0331287 A1
4. Berhe S, Slupe A, Luster C, Charlier HA, Warner DL, Zalkow LH, Burgess EM, Enwerem NM, Bakare O (2010) Synthesis of 3-[(N-carboalkoxy)ethylamino]- indazole-dione derivatives and their biological activities on human liver carbonyl reductase. Bioorg Med Chem 18:134-141
5. Beyer B, Raga AC, Urbina C, Hurtado I (1984) Antiallergic activity of some indazole derivatives. Acta Cient Venez 35:103-106
6. Bhatia M, Ramnath RD, Chevali L, Guglielmotti A (2005) Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am Physiol Gastrointest Liver Physiol 288:1259-1265
7. Bistocchi GA, DeMeo G, Pedini M, Ricci A, Brouilhet H, Boucherie S, Rabaud M, Jacquignon P (1981) N1-substituted 1H-indazole-3-ethyl carboxylates and 1H-indazole-3-hydroxamic acids. Farmaco 36:315-333
8. Bouissane L, El Kazzouli S, Leonce S, Pfeiffer B, Rakib EM, Khouili M, Guillaumet G (2006) Synthesis and biological evaluation of N-(7-indazolyl) benzenesulfonamide derivatives as potent cell cycle inhibitors. Bioorg Med Chem 14:1078-1088
9. Cerecetto H, Gerpe A, Gozalez M, Aran VJ, deOcariz CO (2005) Pharmacological properties of indazole derivatives: recent developments. Mini Rev Med Chem 5:869-878
10. Conway GA, Loeffler LJ, Hall IH (1983) Synthesis and antitumor evaluation of selected 5,6-disubstituted 1(2)H-indazole-4,7-diones. J Med Chem 26:876-884
11. Daidone G, Raffa D, Maggio B, Valeria Raimondi M, Plescia F, Schillaci D (2004) Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study. Eur J Med Chem 39:219-224
12. Drizin I, Gomtsyan A, Bayburt EK, Schmidt RG, Zheng GZ, Perner RJ, DiDomenico S, Koenig JR, Turner SC, Jinkerson TK, Brown BS, Keddy RG, McDonald HA, Honore P, Wismer CT, Marsh KC, Wetter JM, Polakowski JS, Segreti JA, Jarvis MF, Faltynek CR, Lee CH (2006) Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists. Bioorg Med Chem 15:4740-4749
13. Fernandez P, Guillen MI, Gomar F, Aller E, Molina P, Alcaraz MJ (2004) A novel cyclo-oxygenase-2 inhibitor modulates catabolic and anti-inflammatory mediators in osteoarthritis. Biochem Pharmacol 68:417-421
14. Gerpe A, Aguirre G, Boiani L, Cerecetto H, Gonzalez M, Olea-Azar C, Rigol C, Maya JD, Morello A, Piro OE, Aran VJ, Azqueta A, de Cerain AL, Monge A, Rojas MA, Yaluff G (2006) Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies. Bioorg Med Chem 14:3467-3480
15. Gomtsyan A, Bayburt EK, Schmidt RG, Surowy CS, Honore P, Marsh KC, Hannick SM, McDonald HA, Wetter JM, Sullivan JP, Jarvis MF, Faltynek CR, Lee CH (2008) Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H- indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management. J Med Chem 51:392-395
16. Goodman KB, Cui H, Dowdell SE, Gaitanopoulos DE, Ivy RL, Sehon CA, Stavenger RA, Wang GZ, Viet AQ, Xu W, Ye G, Semus SF, Evans C, Fries HE, Jolivette LJ, Kirkpatrick RB, Dul E, Khandekar SS, Yi T, Jung DK, Wright LL, Smith GK, Behm DJ, Bentley R, Doe CP, Hu E, Lee D (2007) Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors. J Med Chem 50:6-9
17. Hadden M, Deering DM, Henderson AJ, Surman MD, Luche M, Khmelnitsky Y, Vickers S, Viggers J, Cheetham S, Guzzo PR (2010) Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity. Bioorg Med Chem Lett 20:7020-7023
18. Hall IH, Williams WL Jr, Wyrick SD, Voorstad PJ (1984) Biological activity of the hypolipidemic agent, N2-n-butylindazolone. J Pharm Sci 73:1788-1791
19. Han F, Shirasaki Y, Fukunaga K (2006) 3-[2-[4-(3-Chloro-2- methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolyl-methyl) -1H-indazole dihydro -chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin. J Pharmacol Exp Ther 317:529-536
20. Hartinger CG, Zorbas-Seifried S, Jakupec MA, Kynast B, Zorbas H (2006) From bench to bedside-preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis( 1H-indazole) ruthenate (III)]. J Inorg Biochem 100:891-904
21. Huang LJ, Shih ML, Chen HS, Pan SL, Teng CM, Lee FY, Kuo SC (2006) Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl) indazoles as novel anti-angiogenic agents. Bioorg Med Chem 14:528-536
22. Iwakubo M, Takami A, Okada Y, Kawata T, Tagami Y, Ohashi H, Sato M, Sugiyama T, Fukushima K, Iijima H (2007) Design and synthesis of Rho kinase inhibitors (II). Bioorg Med Chem 15:350-364
23. Jones P, Altamura S, Boueres J, Ferrigno F, Fonsi M, Giomini C, Lamartina S, Monteagudo E, Ontoria JM, Orsale MV, Palumbi MC, Pesci S, Roscilli G, Scarpelli R, Fademrecht CS, Toniatti C, Rowley M (2009) Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem 52(22):7170-7185
24. Kim SH, Kim HJ, Koo SY, Chung CW, Lee SD, Park HS, Yoon SH, Kwak HS, Seo DO, Park E (2010) US Pat. US 2010/0197673 A1
25. Klein M, Gericke R, Mederski W, Beier N, Lang F (2011) US Pat. US 7,884,126 B2
26. Ko JH, Yeon SW, Ryu JS, Kim TY, Song EH, You HJ, Park RE, Ryu CK (2006) Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7- diones as inhibitors of protein kinase B/Akt. Bioorg Med Chem Lett 16:6001-6005
27. Kuo S, Lee F, Huang T, Teng C, Lee O, Wu C, Hwang C, Hung C (2007) US Pat. US 7,176,230 B2
28. Lee J, Choi H, Kim KH, Jeong S, Park JW, Baek CS, Lee SH (2008) Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors. Bioorg Med Chem Lett 18:2292-2295
29. Liu KG, Robichaud AJ, Bernotas RC, Yan Y, Lo JR, Zhang M, Hughes ZA, Huselton C, Zhang GM, Zhang JY, Kowal DM, Smith DL, Schechter LE, Comery TA (2010) Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists. J Med Chem 53(21):7639-7646
30. Luszczki JJ, Sacharuk A, Wojciechowskam A, Andres-Mach MM, Dudra-Jastrzebska M, Mohamed M, Sawicka KM, Kozinska J, Czuczwar SJ (2006) 7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Pharmacol Rep 58:660-671
31. Martin NI, Derbyshire ER, Marletta MA (2007) Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1. Bioorg Med Chem Lett 17:4938-4941
32. May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA (2006) 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. J Med Chem 49:318-328
33. McFarland JW, Ricketts AP, Newcomb DM, Shively JE, Glazer EA (1992) Anticoccidial activities of 7-bromo-N-(2-imidazolidinylidene)-1H-indazol-6-amine and other alpha 2 adrenergic agonists. Antimicrob Agents Chemother 36:368-371
34. Meyers MJ, Arhancet GB, Hockerman SL, Chen X, Long SA, Mahoney MW, Rico JR, Garland DJ, Blinn JR, Collins JT, Yang S, Huang H, McGee KF, Wendling JM, Dietz JD, Payne MA, Homer BL, Heron MI, Reitz DB, Hu X (2010) Discovery of (3S, 3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g] indazole-7-carboxylic Acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy. J Med Chem 53(16):5979-6002
35. Minu M, Thangadurai A, Wakode SR, Agrawal SS, Narasimhan B (2009) Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3, 3a,4,5,6,7-hexahydro-2H-indazoles. Bioorg Med Chem Lett 19:2960-2964
36. Mishriky N, Ibrahim YA, Girgis AS, Fawzy NG (1999) New 2 H-benz[g]indazoles of anticipated molluscicidal activity. Pharmazie 54:738-742
37. Mosti L, Menozzi G, Schenone P, Tortora G, DiMouro G, Lama M, Marmo E (1987) 1-Substituted 5-dialkylaminomethyl-1,5,6,7-tetrahydroindazol-4-ones with antiinflammatory and analgesic activity. Farmaco 42:259-266
38. Mosti L, Menozzi G, Schenone P, Molinario L, Conte F, Montanario C, Marmoe E (1988) Acetic acids bearing the 1-phenyl-1Hindazole nucleus with analgesic and antiinflammatory activity. Farmaco 43:763-774
39. Mosti L, Menozzi G, Schenone P, Cervo D, Esposito G, Marmo E (1990) 4-Substituted 1-phenyl-1H-indazoles with analgesic, antiinflammatory, antipyretic and local anesthetic activities. Farmaco 45:415-429
40. Mosti L, Menozzi G, Fossa P, Schenone P, Lampa E, Parrillo C, D'Amisco M, Rossi F (1992a) 4-Substituted 1-methyl-1Hindazoles with analgesic, antiinflammatory and antipyretic activities. Farmaco 47:567-584
41. Mosti L, Sansebastiano L, Fossa P, Schenone P, Mattioli F (1992b) 1-Phenyl-1H-indazole derivatives with analgesic and antiinflammatory activities. Farmaco 47:357-365
42. Nagakura M, Ota T, Shimidzu N, Kawamura K, Eto Y, Wada Y (1979) Syntheses and anti-inflammatory actions of 4,5,6,7-tetrahydroindazole-5-carboxylic acids. J Med Chem 22:48-52
43. Nasr MN, Said SA (2003) Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents. Arch Pharm (Weinheim) 336:551-559
44. Park JS, Yu KA, Kang TH, Kim S, Suh YG (2007) Discovery of novel indazole-linked triazoles as antifungal agents. Bioorg Med Chem Lett 17:3486-3490
45. Propker M, Pongracz MJ, Szabo JL (1976) Pharmacological and toxicological studies with 1-benzyl-3-(2,3-dihydroxypropoxy) indazole. Arzneimittelforschung 26:1393-1397
46. Raffa D, Daidone G, Maggio B, Schillaci D, Plescia F (1999) Synthesis and antiproliferative activity of novel 3-(indazol-3-yl)-quinazolin-4(3H)-one and 3-(indazol-3-yl)-benzotriazin-4(3H)-one derivatives. Arch Pharm (Weinheim) 332:317-320
47. Raffa D, Daidone G, Plescia F, Schillaci D, Maggio B, Torta L (2002) Synthesis and antifungal activity of new N-(1-phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides. Farmaco 57:183-187
48. Raffa D, Maggio B, Cascioferro S, Raimondi MV, Schillaci D, Gallo G, Daidone G, Plescia S, Meneghetti F, Bombieri G, Cristina AD, Pipitone RM, Grimaudo S, Tolomeo M (2009) Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides. Eur J Med Chem 44:165-178
49. Raikova SV, Shub GM, Golikov AG, Krivenko AP (2004) Antimicrobial activity of new original 2-aryliden-6-furfuryliden cyclohexanones and hexahydroindazoles on their basis. Antibiot Khimioter 49:21-24
50. Ranise A, Bondavalli F, Schenone P, Lampa E, Greco R, Scafuro M, Marmo E (1984) Derivatives of 4,5,6,7-tetrahydro-7,8,8-trimethyl-3-phenylamino-4, 7-methano-2H-indazole with hypotensive and hypoglycemic activities. Farmaco 39:200-207
51. Rodgers JD, Johnson BL, Wang H, Erickson-Viitanen S, Klabe RM, Bacheler L, Cordova BC, Chang CH (1998) Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups. Bioorg Med Chem Lett 8:715-720
52. Rosati O, Curini M, Marcotullio MC, Macchiarulo A, Perfumi M, Mattioli L, Rismondo F, Cravotto G (2007) Synthesis, docking studies and anti-inflammatory activity of 4,5,6,7-tetrahydro-2Hindazole derivatives. Bioorg Med Chem 15:3463-3473
53. Scarpelli R, Boueres JK, Cerretani M, Ferrigno F, Ontoria JM, Rowley M, Schultz-Fademrecht C, Toniatti C, Jones P (2010) Synthesis and biological evaluation of substituted 2-phenyl-2Hindazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors. Bioorg Med Chem Lett 20:488-492
54. Schenone S, Bruno O, Ranise A, Brullo C, Bondavalli F, Fillipprlli MazzeoF, Capuano A (2003) 2-aryl-3-phenylamino-4,5-dihydro-2 h-benz[g]indazoles with analgesic activity. Farmaco 58:845-849
55. Schindler R, Fleischhauer I, Hofgen N, Sauer W, Egerland U, Poppe H, Heer S, Szelenyi I, Kutscher B, Engel J (1998) 1,5-Disubstituted indazol-3-ols with anti-inflammatory activity. Arch pharm (weinheim) 331:13-21
56. Shimada I, Maeno K, Kazuta K, Kubota H, Kimizuka T, Kimura Y, Hatanaka K, Naitou Y, Wanibuchi F, Sakamoto S, Tsukamoto S (2008) Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g] indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists. Bioorg Med Chem 16:1966-1982
57. Souers AJ, Gao J, Brune M, Bush E, Wodka D, Vasudevan A, Judd AS, Mulhern M, Brodjian S, Dayton B, Shapiro R, Hernandez LE, Marsh KC, Sham HL, Collins CA, Kym PR (2005a) Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-ylethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melaninconcentrating hormone receptor 1 antagonist for the treatment of obesity. J Med Chem 48:1318-1321
58. Souers AJ, Gao J, Wodka D, Judd AS, Mulhern MM, Napier JJ, Brune ME, Bush EN, Brodjian SJ, Dayton BD, Shapiro R, Hernandez LE, Marsh KC, Sham HL, Collins CA, Kym PR (2005b) Synthesis and evaluation of urea-based indazoles as melaninconcentrating hormone receptor 1 antagonists for the treatment of obesity. Bioorg Med Chem Lett 15:2752-2757
59. Yakaiah T, Lingaiah BPV, Naraiah B, Kumar KP, Murthy US (2008) NGdCl(3) catalysed Grieco condensation: a facile approach for the synthesis of novel pyrimidine and annulated pyrimidine fused indazole derivatives in single pot under mild conditions and their anti-microbial activity. Eur J Med Chem 43:341-447
60. Zhang HC, Maryanoff BE, Pandey A, Scarborough RM (2008) US Pat. US 7,417,030 B2
61. Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H, Liu N (2007) Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Pancreas 34:242-247
62. Zoller G, Petry S, Muller G, Heuer H, Baringhaus KH (2005) US Pat. US 2005/0197348 A1
63. Zoller G, Petry S, Muller G, Heuer H, Tennagels N (2010) US Pat. US 7,772,268 B2